Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Jeffrey M, Steele"'
Autor:
Allison M. Field, Robert W. Seabury, Wesley D. Kufel, William Darko, Christopher D. Miller, Keri A. Mastro, Jeffrey M. Steele
Publikováno v:
Surgical Infections. 24:177-182
Autor:
Allison M. Hitchcock, Robert W. Seabury, Wesley D. Kufel, Sara Farooqi, Jeffrey M. Steele, William Darko, Christopher D. Miller, Elizabeth A. Feldman
Publikováno v:
Annals of Pharmacotherapy. 57:669-676
Background: Skin and soft tissue infections (SSTIs) are often caused by gram-positive bacteria that colonize the skin. Given the overuse of antibiotics, SSTIs are increasingly caused by resistant bacteria, including methicillin-resistant Staphylococc
Autor:
Sarah N. Belz, Robert W. Seabury, Jeffrey M. Steele, William Darko, Christopher D. Miller, Luke A. Probst, Wesley D. Kufel
Publikováno v:
Annals of Pharmacotherapy. 57:432-440
Background: Free online adaptive vancomycin dosing calculators are available to estimate area under the concentration-time curve (AUC), but the accuracy of predicting vancomycin AUC using these calculators compared with using a 2-point pharmacokineti
Autor:
Wesley D. Kufel, Jeffrey M. Steele, Scott W. Riddell, Zachary Jones, Pegah Shakeraneh, Timothy P. Endy
Publikováno v:
IDCases, Vol 21, Iss , Pp e00863- (2020)
Cefiderocol is a novel siderophore cephalosporin antibacterial with activity against carbapenem-resistant Gram-negative bacteria including Pseudomonas aeruginosa. We report a medically complex patient treated with compassionate use cefiderocol for an
Externí odkaz:
https://doaj.org/article/32b19229682e4556bf5ffe4e31546d2e
Autor:
Wesley D Kufel, Yasmeen Abouelhassan, Jeffrey M Steele, Ramiro L Gutierrez, Talha Perwez, George Bourdages, David P Nicolau
Publikováno v:
Journal of Antimicrobial Chemotherapy. 77:2737-2741
Background To date, no real-world data are available to describe cefiderocol use in carbapenem-resistant Acinetobacter baumannii (CRAB) meningitis. Furthermore, cefiderocol pharmacokinetic (PK) data to support CNS penetration in human subjects are li
Autor:
Chieh, Chen, Robert W, Seabury, Jeffrey M, Steele, Katie A, Parsels, William, Darko, Christopher D, Miller, Wesley D, Kufel
Publikováno v:
American Journal of Health-System Pharmacy. 79:1273-1280
Purpose While some guidelines recognize the need for β-lactam therapeutic drug monitoring (TDM), there is still a paucity of data regarding the prevalence of and barriers to performing β-lactam TDM in the United States. We sought to estimate the pr
Autor:
Wesley D. Kufel, Katie A. Parsels, Bruce E. Blaine, Jeffrey M. Steele, Rahul Mahapatra, Kristopher M. Paolino, Stephen J. Thomas
Publikováno v:
PharmacotherapyREFERENCES.
The preferred antibiotic salvage regimen for persistent methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) is unclear. We sought to evaluate the effectiveness and safety of vancomycin plus ceftaroline for persistent MRSAB. The primary out
Autor:
Wesley D. Kufel, Katie A. Parsels, Bruce E. Blaine, Jeffrey M. Steele, Robert W. Seabury, Elizabeth A. Asiago-Reddy
Publikováno v:
International Journal of Antimicrobial Agents. :106843
Autor:
Robert W. Seabury, Scott W. Riddell, Luke A. Probst, Wesley D Kufel, William Darko, Joelle Arieno, William F. Paolo, Jeffrey M. Steele, Christopher D. Miller, Gregory M. Cwikla
Publikováno v:
Hosp Pharm
Background: The 2019 Infectious Diseases Society of America community-acquired pneumonia (CAP) guidelines recommend antimethicillin- resistant Staphylococcus aureus (MRSA) therapy in patients with CAP based on previously identified risk factors for M
Publikováno v:
Journal of Antimicrobial Chemotherapy. 76:1379-1391
Cefiderocol is a novel siderophore cephalosporin that forms a complex with extracellular free ferric iron, which leads to transportation across the outer cell membrane to exert its bactericidal activity through cell wall synthesis inhibition. This ph